United Therapeutics (UTHR) Net Cash Flow (2009 - 2026)
United Therapeutics (UTHR) posted Net Cash Flow of -$277.4 million for Q1 2026, down 227.83% sequentially from $217.0 million in Q4 2025, and down 236.85% YoY from $202.7 million in Q1 2025.
United Therapeutics (UTHR) Net Cash Flow (2009 - 2026) Analysis & Trends
United Therapeutics has reported Net Cash Flow for 18 years, with the latest figure at -$277.4 million in Q1 2026.
- Quarterly Net Cash Flow fell 236.85% year-over-year to -$277.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$620.2 million (down 195.65% YoY) and the FY2025 annual result came in at -$140.1 million, down 128.62% from the prior year.
- Net Cash Flow fell to -$277.4 million in Q1 2026 per UTHR's latest filing, from $217.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $217.0 million in Q4 2025 and troughed at -$306.8 million in Q2 2025.
- A 5-year average of $22.6 million and a median of $43.8 million in 2024 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 1885.71% in 2023, down 431.49% in 2023.
- Over 5 years, Net Cash Flow stood at -$5.6 million in 2022, then surged by 1885.71% to $100.0 million in 2023, then surged by 43.3% to $143.3 million in 2024, then jumped by 51.43% to $217.0 million in 2025, then sank by 227.83% to -$277.4 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$277.4 million, $217.0 million, and -$253.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.42 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 523.50 Mn |
| Jun 30, 2026 | 523.50 Mn |
| Mar 31, 2026 | -277.40 Mn |
| Mar 31, 2026 | -277.40 Mn |
| Dec 31, 2025 | 217.00 Mn |
| Dec 31, 2025 | 217.00 Mn |
| Sep 30, 2025 | -253.00 Mn |
| Sep 30, 2025 | -253.00 Mn |
| Jun 30, 2025 | -306.80 Mn |
| Jun 30, 2025 | -306.80 Mn |
| Mar 31, 2025 | 202.70 Mn |
| Mar 31, 2025 | 202.70 Mn |
| Dec 31, 2024 | 143.30 Mn |
| Dec 31, 2024 | 143.30 Mn |
| Sep 30, 2024 | 198.20 Mn |
| Sep 30, 2024 | 198.20 Mn |
| Jun 30, 2024 | 104.20 Mn |
| Jun 30, 2024 | 104.20 Mn |
| Mar 31, 2024 | 43.80 Mn |
| Mar 31, 2024 | 43.80 Mn |